兽医肿瘤学市场规模、份额、增长分析、按治疗类型、按动物类型、按癌症类型、按最终用户、按地区 - 行业预测，2025-2032 年

2023年兽医肿瘤市场规模为2,594亿美元，从2024年的2,907.9亿美元成长到2032年的7,251.4亿美元，预计复合年增长率为12.10%。

宠物癌症发生率上升和动物保健投资增加推动了兽医肿瘤学市场的发展。宠物饲主在兽医治疗上的支出意愿不断增强以及政府的支持措施是推动该市场向前发展的主要趋势。特别是，美国兽医协会估计 25% 的狗一生中会遇到肿瘤，其中癌症往往是死亡的主要原因。此外，COVID-19 大流行加强了宠物与饲主之间的联繫，迫使他们关注宠物的福祉。这一趋势，加上探索新疗法的兽医临床研究的增加，意味着强劲的成长轨迹。政府支持的倡议进一步强化了这一前景，并增加了兽医癌症创新治疗的前景。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管环境
• 案例研究

兽医肿瘤学市场规模：依治疗类型

• 市场概况
• 化疗
  • 口服化疗
  • 注射化疗
• 放射治疗
  • 外部放射治疗
  • 体内放射疗法
• 免疫疗法
  • 单株抗体
  • 癌症疫苗
• 外科手术
  • 肿瘤切除
  • 重组手术

兽医肿瘤学市场规模：依动物类型

• 市场概况
• 伴同性动物
  • 狗
  • 猫
• 家畜
  • 牛
  • 羊
  • 猪

兽医肿瘤学市场规模：按癌症类型

• 市场概况
• 淋巴瘤
• 肥大细胞癌
• 恶性黑色素瘤
• 乳癌和鳞状细胞癌
• 其他的

兽医肿瘤学市场规模：依最终用户分类

• 市场概况
• 动物医院
• 兽医诊所
• 调查机构
• 其他的

兽医肿瘤学市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Zoetis Inc.（USA）
• Elanco Animal Health（USA）
• Boehringer Ingelheim（Germany）
• Merck Animal Health（USA）
• Virbac（France）
• Ceva Sante Animale（France）
• Vetoquinol（France）
• Dechra Pharmaceuticals（UK）
• IDEXX Laboratories（USA）
• Heska Corporation（USA）
• Aratana Therapeutics（USA）
• Karyopharm Therapeutics（USA）
• Regeneus Ltd.（Australia）
• PetCure Oncology（USA）
• Accuray Incorporated（USA）
• Varian Medical Systems（USA）
• Morphogenesis, Inc.（USA）
• Nippon Zenyaku Kogyo Co., Ltd.（Japan）
• Eli Lilly and Company（USA）
• Bayer AG（Germany）

结论和建议

Veterinary Oncology Market size was valued at USD 259.4 Billion in 2023 and is poised to grow from USD 290.79 Billion in 2024 to USD 725.14 Billion by 2032, growing at a CAGR of 12.10% during the forecast period (2025-2032).

The veterinary oncology market is driven by the rising incidence of cancer among pets, coupled with growing investment in animal healthcare. Increased pet owner willingness to spend on veterinary treatment, along with supportive government initiatives, are significant trends propelling this market forward. Notably, the American Veterinary Medical Association estimates that 25% of dogs will face neoplasia in their lifetime, with cancer being the leading cause of death in many cases. Additionally, the COVID-19 pandemic has intensified the bond between pets and owners, promoting greater focus on pet well-being. This trend, combined with an increase in veterinary clinical studies exploring new treatments, signifies a robust growth trajectory. Government-backed initiatives further bolster this landscape, enhancing prospects for innovative cancer therapies in veterinary medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Veterinary Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Veterinary Oncology Market Segmental Analysis

Global Veterinary Oncology Market is segmented by therapy type, animal type, cancer type, end-user and region. Based on therapy type, the market is segmented into chemotherapy, radiation therapy, immunotherapy and surgery. Based on animal type, the market is segmented into companion animals and livestock animals. Based on cancer type, the market is segmented into lymphoma, mast cell cancer, melanoma, mammary and squamous cell cancer and others. Based on end-user, the market is segmented into veterinary hospitals, veterinary clinics, research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Veterinary Oncology Market

One of the primary factors propelling the veterinary oncology market is the increasing occurrence of cancer among companion animals, including dogs and cats. With pets enjoying longer life expectancies, they face similar health challenges as humans, particularly the risk of cancer as they age. This surge in cancer cases among pets has led to a heightened demand for advanced and effective oncology treatments. As pet owners become more aware of the importance of specialized cancer care, the need for innovative therapies and diagnostic solutions in veterinary oncology continues to grow, significantly boosting the market's expansion and development.

Restraints in the Veterinary Oncology Market

The veterinary oncology market faces notable restraints due to the high costs associated with cancer treatments for pets. Many pet owners find the expenses related to diagnostic tests, surgical procedures, medications, and ongoing follow-up care to be significant financial burdens. This elevated pricing can limit the accessibility of veterinary oncology services, making it challenging for some pet owners to pursue necessary treatments for their beloved animals. Ultimately, the financial constraints associated with veterinary oncology can deter pet owners from seeking potentially life-saving interventions, thereby impacting the overall growth and reach of this specialized market.

Market Trends of the Veterinary Oncology Market

The veterinary oncology market is witnessing a significant trend towards personalized medicine, mirroring advancements in human cancer care. As pet owners increasingly seek tailored treatment options, veterinary oncologists are focusing on customized interventions based on the unique genetic profiles and biomarkers of individual animals' cancers. This shift not only enhances treatment efficacy but also aims to reduce potential adverse effects, leading to improved quality of life for pets. The integration of advanced diagnostics and targeted therapies is expected to drive innovation in the market, ultimately expanding growth opportunities for veterinary oncology practitioners and contributing to the broader field of animal health.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Veterinary Oncology Market Size by Therapy Type & CAGR (2025-2032)

• Market Overview
• Chemotherapy
  • Oral Chemotherapy
  • Injectable Chemotherapy
• Radiation Therapy
  • External Beam Radiation Therapy
  • Internal Radiation Therapy
• Immunotherapy
  • Monoclonal Antibodies
  • Cancer Vaccines
• Surgery
  • Tumor Removal
  • Reconstructive Surgery

Global Veterinary Oncology Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Companion Animals
  • Dogs
  • Cats
• Livestock Animals
  • Cattle
  • Sheep
  • Pigs

Global Veterinary Oncology Market Size by Cancer Type & CAGR (2025-2032)

• Market Overview
• Lymphoma
• Mast Cell Cancer
• Melanoma
• Mammary And Squamous Cell Cancer
• Others

Global Veterinary Oncology Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Research Institutes
• Others

Global Veterinary Oncology Market Size & CAGR (2025-2032)

• North America (Therapy Type, Animal Type, Cancer Type, End-User)
  • US
  • Canada
• Europe (Therapy Type, Animal Type, Cancer Type, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Therapy Type, Animal Type, Cancer Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Therapy Type, Animal Type, Cancer Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Therapy Type, Animal Type, Cancer Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aratana Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karyopharm Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneus Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetCure Oncology (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Morphogenesis, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nippon Zenyaku Kogyo Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations